Effects of Systemic Hypothermia on Microcirculation in Conditions of Hemodynamic Stability and in Hemorrhagic Shock

Shock ◽  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Juan Francisco Caminos Eguillor ◽  
Gonzalo Ferrara ◽  
Vanina Siham Kanoore Edul ◽  
María Guillermina Buscetti ◽  
Héctor Saúl Canales ◽  
...  
2002 ◽  
Vol 53 (4) ◽  
pp. 654-662 ◽  
Author(s):  
Xianren Wu ◽  
Jason Stezoski ◽  
Peter Safar ◽  
Wilhelm Behringer ◽  
Rainer Kentner ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0130134 ◽  
Author(s):  
Raúl J. Gazmuri ◽  
Kasen Whitehouse ◽  
Karla Whittinghill ◽  
Alvin Baetiong ◽  
Jeejabai Radhakrishnan

PLoS ONE ◽  
2017 ◽  
Vol 12 (8) ◽  
pp. e0183439 ◽  
Author(s):  
Bin Wang ◽  
Shouming Chen ◽  
Jun Yang ◽  
Linghui Yang ◽  
Jin Liu ◽  
...  

2020 ◽  
Vol 3 (1) ◽  
pp. 43-57 ◽  
Author(s):  
Russel J Reiter ◽  
Qiang Ma ◽  
Ramaswamy Sharma

This review summarizes published reports on the utility of melatonin as a treatment for virus-mediated diseases. Of special note are the data related to the role of melatonin in influencing Ebola virus disease. This infection and deadly condition has no effective treatment and the published works documenting the ability of melatonin to attenuate the severity of viral infections generally and Ebola infection specifically are considered. The capacity of melatonin to prevent one of the major complications of an Ebola infection, i.e., the hemorrhagic shock syndrome, which often contributes to the high mortality rate, is noteworthy. Considering the high safety profile of melatonin, the fact that it is easily produced, inexpensive and can be self-administered makes it an attractive potential treatment for Ebola virus pathology.  


2001 ◽  
Vol 44 (3) ◽  
pp. 385
Author(s):  
Sook Ja Yoon ◽  
Yun Sun Choi ◽  
Chung Ho Shin ◽  
Sung Bum Cho ◽  
Jae Min Cho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document